Antipsychotic-like properties of 5-alpha-reductase inhibitors (Q46691569)

24 December 2017

title

Antipsychotic-like properties of 5-alpha-reductase inhibitors (English)

1 reference

24 December 2017

author

Marco Bortolato

1

1 reference

24 December 2017

Roberto Frau

2

1 reference

24 December 2017

author name string

Marco Orrù

3

1 reference

24 December 2017

Youri Bourov

4

1 reference

24 December 2017

Francesco Marrosu

5

1 reference

24 December 2017

Giampaolo Mereu

6

1 reference

24 December 2017

Paola Devoto

7

1 reference

24 December 2017

Gian L Gessa

8

1 reference

24 December 2017

language of work or name

English

0 references

publication date

19 March 2008

1 reference

24 December 2017

published in

Neuropsychopharmacology

1 reference

24 December 2017

volume

33

1 reference

24 December 2017

issue

13

1 reference

24 December 2017

page(s)

3146-3156

1 reference

24 December 2017

https://scigraph.springernature.com/pub.10.1038/npp.2008.39

exact match

0 references

cites work

Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Stress and neuroactive steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

The neurosteroid pregnenolone sulphate increases dopamine release and the dopaminergic response to morphine in the rat nucleus accumbens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Modification of gonadectomy-induced increases in brain monoamine metabolism by steroid hormones in male and female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Kappa opioid receptor activation disrupts prepulse inhibition of the acoustic startle in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Treatment of Tourette's syndrome with finasteride

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Sensorimotor gating and schizophrenia. Human and animal model studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Extrapyramidal side-effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Allopregnanolone increase in striatal N-methyl-D-aspartic acid evoked [3H]dopamine release is estrogen and progesterone dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Differences in distribution of ages of onset in males and females with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Role of brain allopregnanolone in the plasticity of gamma-aminobutyric acid type A receptor in rat brain during pregnancy and after delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Behavioural interactions between 5-hydroxytryptophan, neuroleptic agents and 5-HT receptor antagonists in modifying rodent responding to aversive situations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Depletion of cortical allopregnanolone potentiates stress-induced increase in cortical dopamine output

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Estrous cycle-dependent changes in basal and ethanol-induced activity of cortical dopaminergic neurons in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Effects of gonadectomy and hormone replacement on brain monoamine synthesis in male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Increased response switching, perseveration and perseverative switching following d-amphetamine in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Steroid control of monoamines in relation to sexual behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

A new look at the 5alpha-reductase inhibitor finasteride.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Negative correlation between negative symptoms of schizophrenia and testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Testosterone modulates mesolimbic dopaminergic activity in male rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

The effects of haloperidol and clozapine on the disruption of sensorimotor gating induced by the noncompetitive glutamate antagonist MK-801.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Pathways to schizophrenia: the impact of environmental factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Sex hormones in psychotic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Gender differences in bipolar disorder: age of onset, course, comorbidity, and symptom presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one affects dopamine-mediated behavior in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Sex differences in schizophrenia, a review of the literature

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FNPP.2008.39

21 January 2018

https://api.crossref.org/works/10.1038%2FNPP.2008.39

7 January 2021

Testosterone and progesterone metabolism in the central nervous system: cellular localization and mechanism of control of the enzymes involved

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Androgen and progesterone metabolism in the central and peripheral nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Neurosteroids, via sigma receptors, modulate the [3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

The sigma1 protein as a target for the non-genomic effects of neuro(active)steroids: molecular, physiological, and behavioral aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Influences of estrogen and/or progesterone on some dopamine related behavior in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

5 alpha-reductase isozymes in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Pharmacology and physiology of stereotyped behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Neurosteroid withdrawal model of perimenstrual catamenial epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Oestrogen effects in schizophrenia and their potential therapeutic implications--review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

The neurosteroid allopregnanolone increases dopamine release and dopaminergic response to morphine in the rat nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Assessment of neuroleptic-like properties of progesterone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

The catalepsy test: its ups and downs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Effects of psychotropic drugs on human erection and ejaculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Correlation of plasma neurosteroid levels to the severity of negative symptoms in male patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Differential regulation of steroid 5alpha-reductase isozymes expression by androgens in the adult rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Behavioural manifestations of anabolic steroid use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Effects of the 5 alpha-reductase inhibitor finasteride on serum levels of gonadal, adrenal, and hypophyseal hormones and its clinical significance: a prospective clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Estrogen increases prepulse inhibition of acoustic startle in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Corticosteroid-induced psychotic and mood disorders: diagnosis defined by DSM-IV and clinical pictures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

BMY-14802, a sigma ligand and potential antipsychotic drug, reverses amphetamine-induced changes in neostriatal single-unit activity in freely moving rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

Stereotyped behavior elicited by amphetamine in the rat: influences of the testes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

7 January 2021

Use of progesterone in the treatment of post-partum psychosis.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

7 January 2021

The effect of hormonal condition on dose-dependent amphetamine-stimulated behaviors in the male rat

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

7 January 2021

The paw test: a behavioural paradigm for differentiating between classical and atypical neuroleptic drugs

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

7 January 2021

Involvement of dopamine receptors in the antipsychotic profile of (-) eticlopride

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

7 January 2021

The role of estrogen in schizophrenia: implications for schizophrenia practice guidelines for women

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

7 January 2021

Gender and bipolar illness

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

7 January 2021

Inhibition of steroid 5 alpha-reductase by unsaturated 3-carboxysteroids

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

7 January 2021

Improvement of general symptoms in a chronic psychotic patient treated with finasteride: case report

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

7 January 2021

Nithsdale Schizophrenia Surveys 24: sexual dysfunction. Case-control study

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

7 January 2021

Differential effects of estrogen and androgen on locomotor activity induced in castrated male rats by amphetamine, a novel environment, or apomorphine

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

7 January 2021

Segregation and linkage analyses of Tourette's syndrome and related disorders

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

7 January 2021

Progesterone releases dopamine in male and female rat striatum: a behavioral and microdialysis study

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

7 January 2021

Stress-induced deoxycorticosterone-derived neurosteroids modulate GABA(A) receptor function and seizure susceptibility.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

7 January 2021

Gonadectomy and sex differences in the behavioral responses to amphetamine and apomorphine of rats

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

7 January 2021

Toward understanding the biology of a complex phenotype: rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

7 January 2021

Testosterone-patch-induced psychotic mania

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

7 January 2021

Functional antagonism of gonadal steroids at the 5-hydroxytryptamine type 3 receptor

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

7 January 2021

The safety of finasteride used in benign prostatic hypertrophy: a non-interventional observational cohort study in 14,772 patients.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.39

7 January 2021

Identifiers

DOI

10.1038/NPP.2008.39

1 reference

24 December 2017

1 reference

24 December 2017